Evofem Biosciences (EVFM) Misses Q4 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Evofem Biosciences Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update
March 4, 2021 4:00 PM ESTSAN DIEGO, March 4, 2021 /PRNewswire/ --Â Evofem Biosciences, Inc. (NASDAQ: EVFM), a commercial stage biopharmaceutical company, today reported financial results for the three- and twelve-month periods ended December 31, 2020.
"2020 was a year of execution for Evofem, marked by... More
